- Home
- HXL vs ACLX Comparison
HXL vs ACLX Comparison
Compare HXL & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HXL | ACLX |
|---|---|---|
| Founded | 1946 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 6.7B |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HXL | ACLX |
|---|---|---|
| Price | $90.11 | $115.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 15 |
| Target Price | $88.30 | ★ $118.17 |
| AVG Volume (30 Days) | 837.2K | ★ 12.1M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,893,900,000.00 | $22,286,000.00 |
| Revenue This Year | $10.09 | $342.39 |
| Revenue Next Year | $12.33 | $170.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $53.88 | $60.36 |
| 52 Week High | $98.26 | $115.14 |
Technical Indicators
Market Signals| Indicator | HXL | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 79.86 |
| Support Level | $88.83 | $63.46 |
| Resistance Level | $93.46 | N/A |
| Average True Range (ATR) | 3.16 | 0.11 |
| MACD | -0.11 | -0.62 |
| Stochastic Oscillator | 84.02 | 84.28 |
Price Performance
Historical ComparisonAbout HXL Hexcel Corporation
Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use primarily in the commercial aerospace and defense markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engine nacelles, and other structures and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.